Effect of atrial natriuretic peptide on muscle sympathetic activity and its reflex control in human heart failure

Circulation

Volumn 99, Issue 14, 1999, Pages 1810-1815

  Abramson, Beth L ^b   Ando, Shin Ichi ^b   Notarius, Catherine F ^b   Rongen, Gerard A ^b   Floras, John S ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

Atrial natriuretic factor; Blood pressure; Heart failure i nervous system, autonomic; Nitroglycerin

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; DRUG EFFECT; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORADRENALIN RELEASE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; STIMULUS RESPONSE; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 0033551188     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.14.1810     Document Type: Article

References (33)

1. Thoren P, Mark AL, Morgan DA, O'Neill TP, Needleman P, Brody MJ. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol. 1986;251(Heart Circ Physiol 20): H1252-H1259.
2. Hirooka Y, Takeshita A, Imaizumi T, Nakamura N, Tomoike H, Nakamura M. Effects of α-human atrial natriuretic peptide on the interrelationship of arterial pressure, aortic nerve activity, and aortic diameter. Circ Res. 1988;63:987-996.
3. Floras JS. Sympathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation. 1990;81:1860-1873.
4. Lang CC, Struthers AD. Interactions between atrial natriuretic factor and the autonomic nervous system. Clin Auton Res. 1991;1:329-336.
5. Butler GC, Senn BL, Floras JS. Influence of atrial natriuretic factor on spontaneous baroreflex sensitivity for heart rate in humans. Hypertension. 1995;25:1167-1171.
6. Floras JS. Inhibitory effect of atrial natriuretic factor on sympathetic ganglionic neurotransmission in humans. Am J Physiol. 1995; 269(Regulatory: Integrative and Camp Physiol 38):R406-R412.
7. Yang RH, Jin H, Wyss M, Chen YF, Oparil S. Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarius. Hypertension. 1992; 19:198-205.
8. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73: 913-919.
9. Hara K, Floras JS. After effects of exercise on haemodynamics and muscle sympathetic nerve activity in young patients with dilated cardiomyopathy. Heart. 1996;75:602-608.
10. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
11. Kaye DM, Lefkovits J, Jenning GF, Begin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cordiol. 1995;26:1257-1263.
12. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol. 1993;22[suppl A]:72A-84A.
13. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang C, Kubo SH, Rudin-Toretesky E, Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
14. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhoffer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation. 1997;95:169-175.
15. Ferguson DW, Berg WJ, Sanders S. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol. 1990;16:1125-1134.
16. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570-578.
17. Kaye DM, Jennings GL, Dart AM, Esler MD. Differential effect of acute baroreceptor unloading on cardiac and total systemic sympathetic tone in congestive heart failure. J Am Coll Cardiol. 1998;31:583-587,
18. Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJ, Scarborough RM, Lewicki JA. Atrial natriuretic factor in normal subjects and heart failure patients. J Clin Invest. 1986;78:1362-1374.
19. Crozier IG, Nicholls MG, Ikram H, Espiner EA, Gomez HJ, Warner NJ. Hemodynamic effects of atrial peptide infusion in heart failure. Lancet. 1986;2:1242-1245.
20. Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, Sonoda R, Ban T, Yasue H, Imura H. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation. 1987;76:115-124.
21. Molina CR, Fowler MB, McCrory S, Peterson G, Myers B, Schroeder JS, Murad F. Hemodynamic, renal, and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. J Am Coll Cardiol. 1988;12: 175-186.
22. Eiskjaer H, Bagger JP, Danielsen H, Jensen JD, Jespersen B, Thomsen K, Pedersen EB. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man. Int J Cardiol. 1991;33:61-74.
23. Azevedo ER, Newton GE, Floras JS, Parker JD. Sympathetic activity responses to ANP in human heart failure. J Am Coll Cardiol. 1997; 29:220A. Abstract.
24. Ando S, Dajani HR, Senn BL, Newton GE, Floras JS. Sympathetic alternans: evidence for arterial baroreflex control of muscle sympathetic nerve activity in congestive heart failure. Circulation. 1997;95:316-319.
25. Wallin BG, Eckberg DL. Sympathetic transients caused by abrupt alterations of carotid baroreceptor activity in humans. Am J Physiol. 1982; 242(Heart Circ Physiol 11):H185-H190.
26. Sanders JS, Ferguson DW. Diastolic pressure determines autonomie responses to pressure perturbation in humans. J Appl Physiol. 1989;66: 800-807.
27. Victor RG, Leimbach WN. Effects of lower body negative pressure on sympathetic discharge to leg muscles in humans. J Appl Physiol. 1987; 63:2558-2562.
28. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol. 1996;27: 358-364.
29. Newton GE, Parker JD. Cardiac sympathetic responses to acute vasodilation: normal ventricular function versus congestive heart failure. Circulation. 1996;94:3161-3167.
30. Atherton JJ, Moore TD, Lele SS, Thomson HL, Galbraith AJ, Belenkie I, Tyberg JV, Frenneaux MP. Diastolic ventricular interaction in chronic heart failure. Lancet. 1997;349:1720-1724.
31. Thoren P. Role of cardiac vagal C-fibers in cardiovascular control. Rev Physiol Biochem Pharmacol. 1979;86:1-94.
32. Noll G, Wenzel RR, de Marchi S, Shaw S, Luscher T. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation. 1997;95:2286-2292.
33. Munzel T, Kurz S, Holtz J, Busse R, Steinhauer H, Just H, Drexler H. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Circulation. 1992;86:1089-1098.